Provided by BFGC Health Committee, Inae Lee, February 2011
The relationship between nasopharyngeal cancer and exposure to formaldehyde has been investigated in seven case–control studies, five of which found elevated risks for overall exposure to formaldehyde or in higher exposure categories, including one in which the increase in risk was statistically significant.
The most recent meta-analysis, which was published in 1997, found an increased overall meta-relative risk for nasopharyngeal cancer.
Excess mortality from leukemia has been observed relatively consistently in six of seven studies of professional workers (i.e. embalmers, funeral parlor workers, pathologists and anatomists). A recently published meta-analysis of exposure to formaldehyde among professionals and the risk for leukemia reported increased overall summary relative risk estimates for embalmers, and for pathologists and anatomists, which did not vary significantly between studies (i.e. the results were found to be homogeneous).
The updated study of British industrial workers failed to demonstrate excess mortality among workers exposed to formaldehyde. The lack of positive findings in this study is difficult to reconcile with the findings from the studies of garment workers and industrial workers in the USA and studies of professionals.
In summary, there is strong but not sufficient evidence for a causal association between leukemia and occupational exposure to formaldehyde. Increased risk for leukemia has consistently been observed in studies of professional workers and in two of three of the most relevant studies of industrial workers. These findings fall slightly short of being fully persuasive because they conflict with the non-positive findings from the British cohort of industrial workers.
A number of studies have found associations between exposure to formaldehyde and cancer at other sites, including the oral cavity, oro- and hypopharynx, pancreas, larynx, lung and brain. However, the Working Group considered that the overall balance of epidemiological evidence did not support a causal role for formaldehyde in relation to these other cancers.
Many studies have evaluated the health effects of inhalation of formaldehyde in humans. Most were carried out in un-sensitized subjects and revealed consistent evidence of irritation of the eyes, nose and throat. Symptoms are rare below 0.5 ppm, and become increasingly prevalent in studies in exposure chambers as concentrations increase. Exposures to up to 3 ppm [3.7 mg/m3] formaldehyde are unlikely to provoke asthma in an un-sensitized individual. Bronchial provocation tests have confirmed the occurrence of occupational asthma due to formaldehyde in small numbers of workers from several centers. The mechanism is probably hypersensitivity, because the reactions are often delayed, there is a latent period of symptomless exposure and unexposed asthmatics do not react to the same concentrations. High levels of formaldehyde probably cause asthmatic reactions by an irritant mechanism. Formaldehyde is one of the commoner causes of contact dermatitis and is thought to act as a sensitizer on the skin
Formaldehyde is proven to be carcinogenic to humans. An increased risk for nasopharyngeal cancer was found and there is strong indication for a causal association between leukemia and occupational exposure to formaldehyde.
There is consistent evidence of irritation of the eyes, nose and throat. High levels of formaldehyde probably cause asthmatic reactions by an irritant mechanism.
The reactions are often delayed; there is a latent period of symptomless exposure, before asthma is provoked. Formaldehyde causes contact dermatitis and is thought to act as a sensitizer on the skin.
On an international level there is a confusingly wide span of maximum contaminant levels (MCL) set in various countries.
Country | Concentration in mg/m³ [ppm] | Interpretation |
High standard |
||
Belgium, Hong Kong, Malaysia Spain | 0.37 [0.3]
0.37 [0.3] |
Ceiling
STEL a |
Medium standard |
||
New Zealand | 1.2 [1.0] | Ceiling |
Low standard |
||
United Kingdom | 2.5 [2.0]
2.5 [2.0] |
STEL
TWA b |
a … STEL: short-term exposure limit
b … TWA: time-weighted average
There are different occupational guidelines even within one country:
Country, Region, Agency | Concentration in mg/m³ [ppm] | Interpretation |
USA |
||
ACGIH (TLV) c
NIOSH (REL) d
OSHA (PEL) e
|
0.37 [0.3]
0.02 [0.016] 0.12 [0.1] 0.9 [0.75] 2.5 [2.0] |
Ceiling
TWA Ceiling TWA STEL |
Canada |
||
Alberta and Quebec
Ontario |
1.2 [1.0]
0.37 [0.3] |
Ceiling
Ceiling |
c … ACGIH: American Conference of Governmental Industrial Hygienists, TLV: Threshold Limit Value
d … NIOSH: The National Institute for Occupational Safety and Health, REL: Recommended Exposure Limit
e … OSHA: Occupational Safety and Health Administration, PEL: Permissible Exposure Limit
Defining exposure limits for certain settings, purposes and groups of people is a partly subjective act. In order to interpret the numbers announced by the various agencies or organizations the following questions must be looked into:
[i] Data from: IARC monographs, volume 88, 2004
[ii] Recent surveys in developed countries worldwide have shown mean indoor formaldehyde concentrations in homes of mainly around 20 to 50 mg/m³, yet some maximum concentrations up to 300 mg/m³. For public and office buildings less data is available, yet here average levels of formaldehyde seem to be about half of the concentration in residential dwellings. (IARC monographs, volume 88, 2004)
[iii] Many different values of an odor threshold have been reported varying from 0.05 to 0.5 mg/m3.
[iv] NOAEL: no observed adverse effect level
[v] For instance, according to the WHO the NOAEL for cell proliferation is 1.25 mg/m³ for long-term exposure; or a CIIT model predicts that cancer risk begins to increase when continuous lifetime exposure reaches 0.6 to 1.0 ppm and becomes significant at levels above that (CIIT Assessment, 1999).
[vi] PEL: permitted exposure limit
Copyright © 2011 Hemato-Centric Life Institute